"Enzyme Precursors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Physiologically inactive substances that can be converted to active enzymes.
| Descriptor ID |
D004792
|
| MeSH Number(s) |
D08.622
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Enzyme Precursors".
Below are MeSH descriptors whose meaning is more specific than "Enzyme Precursors".
This graph shows the total number of publications written about "Enzyme Precursors" by people in this website by year, and whether "Enzyme Precursors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 4 | 5 |
| 1999 | 3 | 0 | 3 |
| 2000 | 1 | 1 | 2 |
| 2001 | 2 | 2 | 4 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 2 | 3 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Enzyme Precursors" by people in Profiles.
-
Ivanciu L, Toso R, Margaritis P, Pavani G, Kim H, Schlachterman A, Liu JH, Clerin V, Pittman DD, Rose-Miranda R, Shields KM, Erbe DV, Tobin JF, Arruda VR, Camire RM. A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia. Nat Biotechnol. 2011 Oct 23; 29(11):1028-33.
-
Biscetti F. Glycosylation of thrombin activatable fibrinolysis inhibitor: why is it so important? Circ Res. 2008 Feb 15; 102(3):278-9.
-
Puli S, Lai JC, Bhushan A. Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones. J Neurooncol. 2006 Sep; 79(2):135-42.
-
Bahnson BJ. Structure, function and interfacial allosterism in phospholipase A2: insight from the anion-assisted dimer. Arch Biochem Biophys. 2005 Jan 1; 433(1):96-106.
-
Mason RW, Bergman CA, Lu G, Frenck Holbrook J, Sol-Church K. Expression and characterization of cathepsin P. Biochem J. 2004 Mar 01; 378(Pt 2):657-63.
-
Li TT, Larrucea S, Souza S, Leal SM, López JA, Rubin EM, Nieswandt B, Bray PF. Genetic variation responsible for mouse strain differences in integrin alpha 2 expression is associated with altered platelet responses to collagen. Blood. 2004 May 1; 103(9):3396-402.
-
Masri SC, Yamani MH, Russell MA, Ratliff NB, Yang J, Almasan A, Apperson-Hansen C, Li J, Starling RC, McCarthy P, Young JB, Bond M. Sustained apoptosis in human cardiac allografts despite histologic resolution of rejection. Transplantation. 2003 Sep 15; 76(5):859-64.
-
Zeuner A, Eramo A, Testa U, Felli N, Pelosi E, Mariani G, Srinivasula SM, Alnemri ES, Condorelli G, Peschle C, De Maria R. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1. Cell Death Differ. 2003 Aug; 10(8):905-13.
-
Chang DW, Ditsworth D, Liu H, Srinivasula SM, Alnemri ES, Yang X. Oligomerization is a general mechanism for the activation of apoptosis initiator and inflammatory procaspases. J Biol Chem. 2003 May 9; 278(19):16466-9.
-
Hsueh RC, Hammill AM, Lee JA, Uhr JW, Scheuermann RH. Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes. BMC Immunol. 2002 Dec 06; 3:16.